Modified drug release refers to the strategic alteration of the release kinetics of a pharmaceutical compound within the body, aiming to optimize therapeutic outcomes while minimizing adverse effects. This approach encompasses a variety of techniques and formulations designed to exert control over the timing, rate, and location of drug delivery. One common strategy involves the development of sustained-release formulations, where the drug is released gradually over an extended period, maintaining therapeutic concentrations in the bloodstream and thereby reducing the frequency of dosing. These formulations often employ specialized drug delivery systems such as hydrogels, liposomes, or microspheres, which encapsulate the active ingredient and control its release through diffusion, erosion, or other mechanisms.
Another approach to modified drug release involves targeting specific sites or tissues within the body to enhance efficacy and reduce systemic side effects. This can be achieved through the use of targeted drug delivery systems that exploit physiological or pathological characteristics of the target tissue, such as pH, temperature, or enzymatic activity. By encapsulating the drug within carriers that selectively release their cargo in response to these cues, researchers can achieve site-specific drug delivery, maximizing therapeutic effects while minimizing off-target effects.
In addition to sustained-release and targeted delivery approaches, modified drug release can also involve the use of novel drug delivery routes and technologies. For example, transdermal patches and implants allow for continuous and controlled release of drugs through the skin or implanted devices, offering advantages such as improved patient compliance and reduced dosing frequency. Similarly, advances in nanotechnology have enabled the development of nanoscale drug delivery systems capable of crossing biological barriers and delivering drugs to specific cellular targets, opening up new possibilities for personalized medicine and precision therapeutics.
Title : Rational design of battery cathode materials
Kyeongjae Cho, University of Texas at Dallas, United States
Title : Pharmaceutical chemistry studies of novel biologics and drugs for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Theoretical modeling in organic nanophotonics: Processes and devices
Alexander Bagaturyants, Retired, Israel
Title : Hot atom chemistry - Past, present and future
Shree Niwas Chaturvedi, Centre for Aptitude Analysis and Talent Search, India
Title : Chemical engineering of vanadium, titanium or chromium zeolites for application in environmental catalysis
Stanislaw Dzwigaj, Sorbonne Université, France
Title : Distal functionalization via transition metal catalysis
Haibo Ge, Texas Tech University, United States